Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amphastar Pharmaceuticals Inc (AMPH) vs United States Brent Oil Fund LP (BNO) Price & Performance

Amphastar Pharmaceuticals IncTrade
United States Brent Oil Fund LPTrade

Price performance (Past 24H)

Key statistics

Amphastar Pharmaceuticals Inc vs United States Brent Oil Fund LP — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $863.95M), while United States Brent Oil Fund LP trades at $51.23. The key difference: United States Brent Oil Fund LP is trading nearer its 52-week high, Amphastar Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.

AMPHBNO
Market Cap
$863.95M
Sector
HealthCommodities - Energy
52-Week High
$30.81$60.13
52-Week Low
$16.87$27.20
Enterprise Value
$1.26B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Amphastar Pharmaceuticals Inc

AMPH trades at $20.78, up 4.9% today, with a bullish technical signal supported by moving averages. The stock shows mixed earnings performance with Q2 2026 beating estimates but Q1 and Q4 2025 missing. Fundamentals remain solid with a 10.76% net margin and reasonable valuation at 12.02 P/E. Recent news highlights Q2 2026 results and strategic shift toward proprietary drugs.

Outlook is cautiously optimistic with growth supported by new product launches, though regulatory risks and earnings volatility pose challenges. Analyst sentiment is mixed with 25% buy ratings but majority hold recommendations. The stock offers value but requires monitoring of FDA developments and earnings consistency.

United States Brent Oil Fund LP

BNO, a US-listed exchange-traded product tracking Brent crude oil futures, trades at $46.93, down 0.93% amid bearish technical signals. The overall technical outlook is bearish, with moving averages indicating selling pressure, while oscillators remain neutral. Recent news highlights Middle East tensions, particularly the deadlock over the Strait of Hormuz, influencing oil price volatility and investor sentiment.

The outlook for BNO is heavily tied to geopolitical developments and oil supply dynamics. Risks include prolonged Middle East instability and oil price corrections, but potential supply disruptions could offer upside. Investors should monitor OPEC decisions and US-Iran negotiations for directional cues, as these factors drive near-term performance.

Returns comparison

Trailing returns across standard periods

About Amphastar Pharmaceuticals Inc

Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.

Read more on AMPH

About United States Brent Oil Fund LP

BNO is a commodity ETF that tracks the daily price of Brent crude oil futures. It provides exposure to the international oil benchmark, which often trades at a premium to the U.S. WTI benchmark, and is primarily used for short-term trading due to roll costs.

Read more on BNO